Samuele Ferrari: Launching a New Era in Hematopoietic Genome Editing Research
Samuele Ferrari, Assistant Professor of Molecular Biology at Libera Università Vita-Salute San Raffaele, shared a post on LinkedIn:
“A new chapter begins in January 2027!
I am thrilled to announce that I will be launching my independent research group, the Genome Editing and Clonal Dynamics of Hematopoiesis Unit, at the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget) in Milan, Italy!
Edit. Trace. Understand. Cure.
Four words that capture the vision of our lab.
Our research will explore how genetic alterations shape the fate of hematopoietic stem cells, how individual clones emerge, evolve, and compete throughout life, and how these processes contribute to aging, inflammation, and disease.
By combining genome editing, stem cell biology, and advanced omics-based lineage tracing, we aim to reconstruct the genetic history of blood cells and uncover the mechanisms driving clonal evolution in health and disease.
Alongside these fundamental questions, a major focus of the lab will be the development of innovative genome editing strategies, with the goal of advancing our ability to investigate biological mechanisms and develop safer, more effective precision therapies for blood diseases.
We will keep having the privilege of working within the unique environment of SR-Tiget, an exceptional ecosystem that brings together cutting-edge basic research, technological innovation, and clinical expertise, creating unique opportunities to translate scientific discoveries into new therapeutic strategies that can change patients’ lives.
We are looking for highly motivated and curious scientists to join this new adventure!
Two exciting opportunities:
- PhD candidates – Rarefind cofund
Call Open – Deadline: December 31, 2026 - Postdoctoral researchers – Beyond cofund
Next call opening early 2027… Stay tuned!
If you are passionate about genome editing, hematopoietic stem cell biology, and somatic genetics, we would love to hear from you! Feel free to reach out or share this post with anyone who might be interested!
I am deeply grateful to SR-Tiget, Ospedale San Raffaele, Libera Università Vita-Salute San Raffaele, Fondazione Telethon, and especially to my mentor, Luigi Naldini, for their continued support.
A special thank you also goes to the brilliant and passionate scientists who have joined me on this new adventure, and to the many collaborators and colleagues who have supported our research along the way.”
Stay updated with Hemostasis Today.
-
Nov 14, 2026, 14:17Stefan Hofer: International Training in Postpartum Hemorrhage Management
-
Nov 14, 2026, 14:14Expanding Global Access to Gene Therapy – WFH
-
Nov 14, 2026, 14:11Cedric Hermans: Advancing Haemophilia Care Through Innovation and Global Access
-
Nov 14, 2026, 14:08Bruno Pougault: Lupus Anticoagulant Testing During DOAC Therapy
-
Nov 14, 2026, 14:08Francinny Alves Kelly: AHA Scientific Sessions 2026 Features Research on CHA₂DS₂-VASc and Transhepatic AF Ablation
-
Nov 14, 2026, 14:03Newborn Vitamin K Prophylaxis and the Risk of Bleeding – JAMA
-
Nov 14, 2026, 14:03Denis Oduor: Shaping the Future of Transfusion Medicine at Terumo BCT Africa Hackathon 2026
-
Nov 14, 2026, 14:01Maria Elisa Mancuso: Shaping the Future of Hemophilia Care Together!
-
Nov 14, 2026, 13:58Deniz Aslan: Advancing Pediatric Beta-Thalassemia Screening